Aurora Cannabis | ACB - Sales Revenues


Aurora Cannabis reported CAD90.37M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Altria USD 5.08B 170M Dec/2025
ANI Pharmaceuticals USD 227.81M 16.44M Sep/2025
Assertio Holdings USD 29.2M 1.92M Sep/2024
Boston Beer USD 385.7M 151.8M Dec/2025
British American Tobacco GBP 13.5B 1.43B Dec/2025
Canopy Growth CAD 66.68M 5.45M Sep/2025
Constellation Brands USD 2.22B 258.2M Sep/2025
Cronos Group USD 36.34M 2.88M Sep/2025
Imperial Brands GBP 17.57B 8.91B Sep/2025
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Molson Coors Brewing USD 2.66B 310M Dec/2025
Nektar Therapeutics USD 24.12M 635K Sep/2024
Organigram Holdings CAD 80.06M 9.27M Sep/2025
Philip Morris International USD 10.4B 400M Dec/2025
Tilray USD 217.51M 74.75M Dec/2025